Fidelity Bank Plc has said that the share purchase transaction of its Managing Director/Chief Executive Officer (CEO) is in compliance with regulatory guidelines.
In a statement by Meksley Nwagboh, Divisional Head, Brand & Communications Fidelity Bank Plc, the bank said “We are constrained to respond to a patently false, misleading and malicious publication against Fidelity Bank Plc and its MD/CEO, Dr. Nneka Onyeali-Ikpe, by Sahara Reporters.”
“The misleading article, which was published on May 21, 2025 contained fabricated information about the Bank and its MD/
CEO including blatantly false allegations that our MD/CEO took personal advantage of material price sensitive information
to engage in insider trading and used the Bank’s funds to purchase 18 million units of its shares”, the statement further read.